Isracann Biosciences

(OTC) ISCNF

Current Price$0.00

Market CapN/A

Since IPO (2019)-100%

5 Year-100%

1 Year+0%

1 Month+0%

Isracann Biosciences Financials at a Glance

Market Cap

N/A

Revenue (TTM)

CA$0.00

Net Income (TTM)

-CA$4.54M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-341.97 (Low)

Dividend

$0.00

Beta (Volatility)

-341.97 (Low)

Price

$0.00

Volume

172

Open

$0.00

Price

$0.00

Volume

172

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Oct 7, 2024

Dividend

$0.00

Beta (Volatility)

-341.97 (Low)

Price

$0.00

Volume

172

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Oct 7, 2024

ISCNF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Isracann Biosciences

Industry

Pharmaceuticals

Sector

Health Care

CEO

Philippe Floucault

Website

www.isracann.com

Headquarters

Vancouver, BC V7X 1L3, CA

ISCNF Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-0%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

172

Avg. Volume

4.21K

Financials (TTM)

Gross Profit

-CA$41.73K

Operating Income

-CA$2.39M

EBITDA

-CA$2.39M

Operating Cash Flow

-CA$1.75M

Capital Expenditure

CA$0.00

Free Cash Flow

-CA$1.75M

Cash & ST Invst.

CA$213.94K

Total Debt

CA$0.00

Isracann Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q1 2023YOY CHG

Revenue

CA$0.00

N/A

Gross Profit

-CA$10.43K

+0.0%

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-CA$316.00K

+32.6%

EBITDA

-CA$305.56K

+31.2%

Quarterly Fundamentals

Name

Q1 2023YOY CHG

Total Cash

CA$198.05K

-85.8%

Total Debt

CA$0.00

N/A

Accounts Receivable

CA$83.21K

-14.9%

Inventory

CA$0.00

N/A

Long Term Debt

CA$0.00

N/A

Short Term Debt

CA$0.00

N/A

Return on Assets

-1.15%

N/A

Return on Invested Capital

-0.08%

N/A

Free Cash Flow

-CA$163.40K

+63.1%

Operating Cash Flow

-CA$163.40K

+63.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RAPHRaphael Pharmaceutical Inc.

RAPHRaphael Pharmaceutical Inc.$1.40+0.00%

GBLPGlobal Pharmatech, Inc.

GBLPGlobal Pharmatech, Inc.$0.08+0.00%

MEDIFMediPharm Labs Corp.

MEDIFMediPharm Labs Corp.$0.05+0.94%

AVCNFAvicanna Inc.

AVCNFAvicanna Inc.$0.08+1.78%

MRESInstitute of Biomedical Research Corp.

MRESInstitute of Biomedical Research Corp.$0.00+0.00%

CWBHFCharlotte's Web Holdings, Inc.

CWBHFCharlotte's Web Holdings, Inc.$0.39-1.27%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CUPRCuprina (Cayman)

CUPRCuprina (Cayman)$5.90+1.45%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.98+0.00%

DSYBig Tree Cloud

DSYBig Tree Cloud$5.38+0.39%

UBXGU-bx Technology

UBXGU-bx Technology$7.73+0.61%

INTCIntel

INTCIntel$123.03+0.05%

SMCISuper Micro Computer

SMCISuper Micro Computer$31.66-0.01%

NOKNokia

NOKNokia$14.91+0.06%

Questions About ISCNF

What is the current price of Isracann Biosciences?

Isracann Biosciences is trading at $0.00 per share.

What is the 52-week range for Isracann Biosciences?

Over the past 52 weeks, Isracann Biosciences has traded between $0.00 and $0.00.

How much debt does Isracann Biosciences have?

As of the most recent reporting period, Isracann Biosciences reported total debt of CA$0.00.

How much cash does Isracann Biosciences have on hand?

Isracann Biosciences reported CA$169.14K in cash and cash equivalents in its most recent financial results.

What is Isracann Biosciences’s dividend yield?

Isracann Biosciences does not currently have a dividend yield.

Isracann Biosciences

Isracann Biosciences Financials at a Glance

ISCNF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Isracann Biosciences

ISCNF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Isracann Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ISCNF

What is the current price of Isracann Biosciences?

What is the 52-week range for Isracann Biosciences?

How much debt does Isracann Biosciences have?

How much cash does Isracann Biosciences have on hand?

What is Isracann Biosciences’s dividend yield?

Premium Investing Services